BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 2010;23:590-615. [PMID: 20610825 DOI: 10.1128/cmr.00078-09] [Cited by in Crossref: 373] [Cited by in F6Publishing: 178] [Article Influence: 31.1] [Reference Citation Analysis]
Number Citing Articles
1 Dat TTH, Cuc NTK, Cuong PV, Smidt H, Sipkema D. Diversity and Antimicrobial Activity of Vietnamese Sponge-Associated Bacteria. Mar Drugs 2021;19:353. [PMID: 34206202 DOI: 10.3390/md19070353] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Prathapan P. A determination of pan-pathogen antimicrobials? Medicine in Drug Discovery 2022. [DOI: 10.1016/j.medidd.2022.100120] [Reference Citation Analysis]
3 Nanishi E, Nishio H, Takada H, Yamamura K, Fukazawa M, Furuno K, Mizuno Y, Saigo K, Kadoya R, Ohbuchi N, Onoe Y, Yamashita H, Nakayama H, Hara T, Ohno T, Takahashi Y, Hatae K, Harada T, Shimose T, Kishimoto J, Ohga S, Hara T. Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open-Label, Randomized Control Study. J Am Heart Assoc 2017;6:e005370. [PMID: 28684643 DOI: 10.1161/JAHA.116.005370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
4 Melnik BC, Schmitz G. Are therapeutic effects of antiacne agents mediated by activation of FoxO1 and inhibition of mTORC1? Exp Dermatol 2013;22:502-4. [PMID: 23800068 DOI: 10.1111/exd.12172] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
5 Gupta A, Ökesli-Armlovich A, Morgens D, Bassik MC, Khosla C. A genome-wide analysis of targets of macrolide antibiotics in mammalian cells. J Biol Chem 2020;295:2057-67. [PMID: 31915244 DOI: 10.1074/jbc.RA119.010770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Takemori N, Nakamura M, Kojima M, Eishi Y. Successful treatment in a case of Propionibacterium acnes-associated sarcoidosis with clarithromycin administration: a case report. J Med Case Rep 2014;8:15. [PMID: 24428939 DOI: 10.1186/1752-1947-8-15] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
7 Linssen RSN, Ma J, Bem RA, Rubin BK. Rational use of mucoactive medications to treat pediatric airway disease. Paediatr Respir Rev 2020;36:8-14. [PMID: 32653467 DOI: 10.1016/j.prrv.2020.06.007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Zhou X, Gu D, Hou G. Erythromycin attenuates metalloprotease/anti-metalloprotease imbalance in cigarette smoke-induced emphysema in rats via the mitogen-activated protein kinase/nuclear factor-κB activation pathway. Mol Med Rep 2017;15:2983-90. [PMID: 28358431 DOI: 10.3892/mmr.2017.6416] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
9 Patel A, Joseph J, Periasamy H, Mokale S. Azithromycin in Combination with Ceftriaxone Reduces Systemic Inflammation and Provides Survival Benefit in a Murine Model of Polymicrobial Sepsis. Antimicrob Agents Chemother 2018;62:e00752-18. [PMID: 29967025 DOI: 10.1128/AAC.00752-18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
10 Piras C, Pintus R, Pruna D, Dessì A, Atzori L, Fanos V. Pediatric Acute-onset Neuropsychiatric Syndrome and Mycoplasma Pneumoniae Infection: A Case Report Analysis with a Metabolomics Approach. Curr Pediatr Rev 2020;16:183-93. [PMID: 31642785 DOI: 10.2174/1573396315666191022102925] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
11 Desmonts de Lamache D, Moges R, Siddiq A, Allain T, Feener TD, Muench GP, McKenna N, Yates RM, Buret AG. Immuno-modulating properties of Tulathromycin in porcine monocyte-derived macrophages infected with porcine reproductive and respiratory syndrome virus. PLoS One 2019;14:e0221560. [PMID: 31442273 DOI: 10.1371/journal.pone.0221560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hong YH, Weng LW, Chang CC, Hsu HF, Wang CP, Wang SW, Houng JY. Anti-inflammatory effects of Siegesbeckia orientalis ethanol extract in in vitro and in vivo models. Biomed Res Int 2014;2014:329712. [PMID: 25328884 DOI: 10.1155/2014/329712] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
13 Hui DS, Lee N, Chan PK, Beigel JH. The role of adjuvant immunomodulatory agents for treatment of severe influenza. Antiviral Res 2018;150:202-16. [PMID: 29325970 DOI: 10.1016/j.antiviral.2018.01.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 11.0] [Reference Citation Analysis]
14 Thouvenin G, Nathan N, Epaud R, Clement A. Diffuse parenchymal lung disease caused by surfactant deficiency: dramatic improvement by azithromycin. BMJ Case Rep 2013;2013:bcr2013009988. [PMID: 23814005 DOI: 10.1136/bcr-2013-009988] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
15 Al-Darraji A, Haydar D, Chelvarajan L, Tripathi H, Levitan B, Gao E, Venditto VJ, Gensel JC, Feola DJ, Abdel-Latif A. Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease. PLoS One 2018;13:e0200474. [PMID: 30001416 DOI: 10.1371/journal.pone.0200474] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
16 Rello J, Valenzuela-Sánchez F, Ruiz-Rodriguez M, Moyano S. Sepsis: A Review of Advances in Management. Adv Ther 2017;34:2393-411. [PMID: 29022217 DOI: 10.1007/s12325-017-0622-8] [Cited by in Crossref: 102] [Cited by in F6Publishing: 87] [Article Influence: 20.4] [Reference Citation Analysis]
17 Nobel YR, Cox LM, Kirigin FF, Bokulich NA, Yamanishi S, Teitler I, Chung J, Sohn J, Barber CM, Goldfarb DS, Raju K, Abubucker S, Zhou Y, Ruiz VE, Li H, Mitreva M, Alekseyenko AV, Weinstock GM, Sodergren E, Blaser MJ. Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nat Commun 2015;6:7486. [PMID: 26123276 DOI: 10.1038/ncomms8486] [Cited by in Crossref: 213] [Cited by in F6Publishing: 194] [Article Influence: 30.4] [Reference Citation Analysis]
18 Chibber P, Haq SA, Ahmed I, Andrabi NI, Singh G. Advances in the possible treatment of COVID-19: A review. Eur J Pharmacol 2020;883:173372. [PMID: 32682787 DOI: 10.1016/j.ejphar.2020.173372] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
19 Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GE. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality. Int Immunopharmacol 2022;104:108516. [PMID: 35032828 DOI: 10.1016/j.intimp.2021.108516] [Reference Citation Analysis]
20 Li HB, Li N, Wen SR, Qiang MY, Yang ZH, Dong TX, Li YY, Kuang YQ. Effect of Antifungal-Treated Host Macrophages on Candida glabrata. Can J Infect Dis Med Microbiol 2021;2021:8838444. [PMID: 33680221 DOI: 10.1155/2021/8838444] [Reference Citation Analysis]
21 O'Donnell AE. Medical management of bronchiectasis. J Thorac Dis 2018;10:S3428-35. [PMID: 30505530 DOI: 10.21037/jtd.2018.09.39] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
22 Brooks K, Caruthers RL, Schumacher KR, Stringer KA. Pharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease. Pharmacotherapy 2013;33:922-34. [PMID: 23686915 DOI: 10.1002/phar.1290] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
23 Li H, Liu DH, Chen LL, Zhao Q, Yu YZ, Ding JJ, Miao LY, Xiao YL, Cai HR, Zhang DP, Guo YB, Xie CM. Meta-analysis of the adverse effects of long-term azithromycin use in patients with chronic lung diseases. Antimicrob Agents Chemother 2014;58:511-7. [PMID: 24189261 DOI: 10.1128/AAC.02067-13] [Cited by in Crossref: 37] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
24 Pestell RG, Rizvanov AA. Antibiotics for cancer therapy. Oncotarget 2015;6:2587-8. [PMID: 25739117 DOI: 10.18632/oncotarget.3388] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
25 Yoshizawa S, Tateda K, Saga T, Ishii Y, Yamaguchi K. Virulence-suppressing effects of linezolid on methicillin-resistant Staphylococcus aureus: possible contribution to early defervescence. Antimicrob Agents Chemother 2012;56:1744-8. [PMID: 22290944 DOI: 10.1128/AAC.05430-11] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
26 Venditto VJ, Haydar D, Abdel-Latif A, Gensel JC, Anstead MI, Pitts MG, Creameans J, Kopper TJ, Peng C, Feola DJ. Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19. Front Immunol 2021;12:574425. [PMID: 33643308 DOI: 10.3389/fimmu.2021.574425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
27 Haydar D, Cory TJ, Birket SE, Murphy BS, Pennypacker KR, Sinai AP, Feola DJ. Azithromycin Polarizes Macrophages to an M2 Phenotype via Inhibition of the STAT1 and NF-κB Signaling Pathways. J Immunol 2019;203:1021-30. [PMID: 31263039 DOI: 10.4049/jimmunol.1801228] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
28 Nippes RP, Macruz PD, da Silva GN, Neves Olsen Scaliante MH. A critical review on environmental presence of pharmaceutical drugs tested for the covid-19 treatment. Process Saf Environ Prot 2021;152:568-82. [PMID: 34226801 DOI: 10.1016/j.psep.2021.06.040] [Reference Citation Analysis]
29 Willing BP, Russell SL, Finlay BB. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol. 2011;9:233-243. [PMID: 21358670 DOI: 10.1038/nrmicro2536] [Cited by in Crossref: 393] [Cited by in F6Publishing: 359] [Article Influence: 35.7] [Reference Citation Analysis]
30 Namkoong H, Ishii M, Fujii H, Yagi K, Asami T, Asakura T, Suzuki S, Hegab AE, Kamata H, Tasaka S, Atarashi K, Nakamoto N, Iwata S, Honda K, Kanai T, Hasegawa N, Koyasu S, Betsuyaku T. Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia. PLoS Pathog 2018;14:e1006955. [PMID: 29621339 DOI: 10.1371/journal.ppat.1006955] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
31 Hakemi Vala M, Eyvazi S, Goudarzi H, Sarie HR, Gholami M. Evaluation of Clarithromycin Resistance Among Iranian Helicobacter pylori Isolates by E-Test and Real-Time Polymerase Chain Reaction Methods. Jundishapur J Microbiol 2016;9:e29839. [PMID: 27540451 DOI: 10.5812/jjm.29839] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
32 Metersky ML, Priya A, Mortensen EM, Lindenauer PK. Association Between the Order of Macrolide and Cephalosporin Treatment and Outcomes of Pneumonia. Open Forum Infect Dis 2017;4:ofx141. [PMID: 28948176 DOI: 10.1093/ofid/ofx141] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Falcone M, Russo A, Shindo Y, Farcomeni A, Pieralli F, Cangemi R, Liu J, Xia J, Okumura J, Sano M, Jones C, Vannucchi V, Mancone M, Micek S, Xu F, Violi F, Kollef M. A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia. Antimicrob Agents Chemother 2019;63:e01556-18. [PMID: 30509940 DOI: 10.1128/AAC.01556-18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 German EL, Al-Hakim B, Mitsi E, Pennington SH, Gritzfeld JF, Hyder-Wright AD, Banyard A, Gordon SB, Collins AM, Ferreira DM. Anti-protein immunoglobulin M responses to pneumococcus are not associated with aging. Pneumonia (Nathan) 2018;10:5. [PMID: 29992080 DOI: 10.1186/s41479-018-0048-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Yuan J, Zhao M, Li R, Huang Q, Rensing C, Raza W, Shen Q. Antibacterial Compounds-Macrolactin Alters the Soil Bacterial Community and Abundance of the Gene Encoding PKS. Front Microbiol 2016;7:1904. [PMID: 27965639 DOI: 10.3389/fmicb.2016.01904] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
36 An TJ, Rhee CK, Kim JH, Lee YR, Chon JY, Park CK, Yoon HK. Effects of Macrolide and Corticosteroid in Neutrophilic Asthma Mouse Model. Tuberc Respir Dis (Seoul) 2018;81:80-7. [PMID: 29332324 DOI: 10.4046/trd.2017.0108] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
37 Suzaki I, Hirano K, Arai S, Maruyama Y, Mizuyoshi T, Tokudome T, Fujii N, Kobayashi H. Primary Ciliary Dyskinesia with Refractory Chronic Rhinosinusitis. Am J Case Rep 2020;21:e923270. [PMID: 32862191 DOI: 10.12659/AJCR.923270] [Reference Citation Analysis]
38 Ekmekciu I, von Klitzing E, Fiebiger U, Neumann C, Bacher P, Scheffold A, Bereswill S, Heimesaat MM. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment. Front Cell Infect Microbiol. 2017;7:167. [PMID: 28529928 DOI: 10.3389/fcimb.2017.00167] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
39 Franco PS, Gois PSG, de Araújo TE, da Silva RJ, de Freitas Barbosa B, de Oliveira Gomes A, Ietta F, Dos Santos LA, Dos Santos MC, Mineo JR, Ferro EAV. Brazilian strains of Toxoplasma gondii are controlled by azithromycin and modulate cytokine production in human placental explants. J Biomed Sci 2019;26:10. [PMID: 30665403 DOI: 10.1186/s12929-019-0503-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
40 Stellari FF, Sala A, Donofrio G, Ruscitti F, Caruso P, Topini TM, Francis KP, Li X, Carnini C, Civelli M, Villetti G. Azithromycin inhibits nuclear factor-κB activation during lung inflammation: an in vivo imaging study. Pharmacol Res Perspect 2014;2:e00058. [PMID: 25505605 DOI: 10.1002/prp2.58] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
41 Sulis G, Batomen B, Kotwani A, Pai M, Gandra S. Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis. PLoS Med 2021;18:e1003682. [PMID: 34197449 DOI: 10.1371/journal.pmed.1003682] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
42 Laserna E, Sibila O, Fernandez JF, Maselli DJ, Mortensen EM, Anzueto A, Waterer G, Restrepo MI. Impact of macrolide therapy in patients hospitalized with Pseudomonas aeruginosa community-acquired pneumonia. Chest 2014;145:1114-20. [PMID: 24458223 DOI: 10.1378/chest.13-1607] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
43 Regmi SC, Park SY, Kim SJ, Banskota S, Shah S, Kim DH, Kim JA. The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt. PLoS One 2015;10:e0141753. [PMID: 26544726 DOI: 10.1371/journal.pone.0141753] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
44 Zang M, Adams FG, Hassan KA, Eijkelkamp BA. The Impact of Omega-3 Fatty Acids on the Evolution of Acinetobacter baumannii Drug Resistance. Microbiol Spectr 2021;:e0145521. [PMID: 34762519 DOI: 10.1128/Spectrum.01455-21] [Reference Citation Analysis]
45 Pincheira MA, Bacharier LB, Castro-Rodriguez JA. Efficacy of Macrolides on Acute Asthma or Wheezing Exacerbations in Children with Recurrent Wheezing: A Systematic Review and Meta-analysis. Paediatr Drugs 2020;22:217-28. [PMID: 31939108 DOI: 10.1007/s40272-019-00371-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
46 Arabi YM, Deeb AM, Al-Hameed F, Mandourah Y, Almekhlafi GA, Sindi AA, Al-Omari A, Shalhoub S, Mady A, Alraddadi B, Almotairi A, Al Khatib K, Abdulmomen A, Qushmaq I, Solaiman O, Al-Aithan AM, Al-Raddadi R, Ragab A, Al Harthy A, Kharaba A, Jose J, Dabbagh T, Fowler RA, Balkhy HH, Merson L, Hayden FG; Saudi Critical Care Trials group. Macrolides in critically ill patients with Middle East Respiratory Syndrome. Int J Infect Dis 2019;81:184-90. [PMID: 30690213 DOI: 10.1016/j.ijid.2019.01.041] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 20.7] [Reference Citation Analysis]
47 Chen CL, Huang Y, Martinez-Garcia MA, Yuan JJ, Li HM, de la Rosa-Carrillo D, Han XR, Chen RC, Guan WJ, Zhong NS. The Role of Epstein-Barr Virus in Adults With Bronchiectasis: A Prospective Cohort Study. Open Forum Infect Dis 2020;7:ofaa235. [PMID: 32766379 DOI: 10.1093/ofid/ofaa235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Hart JD, Samikwa L, Sikina F, Kalua K, Keenan JD, Lietman TM, Burr SE, Bailey RL. Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial. Am J Trop Med Hyg 2020;103:1329-34. [PMID: 32342841 DOI: 10.4269/ajtmh.19-0619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
49 Masekela R, Green RJ. The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis. Mediators Inflamm 2012;2012:134605. [PMID: 22570510 DOI: 10.1155/2012/134605] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
50 Maekawa T, Tamura H, Domon H, Hiyoshi T, Isono T, Yonezawa D, Hayashi N, Takahashi N, Tabeta K, Maeda T, Oda M, Ziogas A, Alexaki VI, Chavakis T, Terao Y, Hajishengallis G. Erythromycin inhibits neutrophilic inflammation and mucosal disease by upregulating DEL-1. JCI Insight 2020;5:136706. [PMID: 32603314 DOI: 10.1172/jci.insight.136706] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
51 Ozyurtlu F, Cetin N, Yavuz V. Drug-induced QTc interval prolongation in PCR-positive non-ICU COVID-19 patients with diverse findings on chest computed tomography. Int J Clin Pract 2021;:e14583. [PMID: 34185352 DOI: 10.1111/ijcp.14583] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Chen IL, Huang HC, Chang YH, Huang HY, Yeh WJ, Wu TY, Suen JL, Yang SN, Hung CH. Effect of antibiotic use for acute bronchiolitis on new-onset asthma in children. Sci Rep 2018;8:6090. [PMID: 29666383 DOI: 10.1038/s41598-018-24348-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
53 Olveira C, Padilla A, Dorado A, Contreras V, Garcia-Fuentes E, Rubio-Martin E, Porras N, Doña E, Carmona A, Olveira G. Inflammation and Oxidation Biomarkers in Patients with Cystic Fibrosis: The Influence of Azithromycin. Eurasian J Med 2017;49:118-23. [PMID: 28638254 DOI: 10.5152/eurasianjmed.2017.17010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
54 Zarkesh K, Entezar-Almahdi E, Ghasemiyeh P, Akbarian M, Bahmani M, Roudaki S, Fazlinejad R, Mohammadi-Samani S, Firouzabadi N, Hosseini M, Farjadian F. Drug-based therapeutic strategies for COVID-19-infected patients and their challenges. Future Microbiol 2021;16:1415-51. [PMID: 34812049 DOI: 10.2217/fmb-2021-0116] [Reference Citation Analysis]
55 Tarran R, Sabater JR, Clarke TC, Tan CD, Davies CM, Liu J, Yeung A, Garland AL, Stutts MJ, Abraham WM, Phillips G, Baker WR, Wright CD, Wilbert S. Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion. Am J Physiol Lung Cell Mol Physiol 2013;304:L746-56. [PMID: 23542952 DOI: 10.1152/ajplung.00292.2012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
56 Lekagul A, Tangcharoensathien V, Mills A, Rushton J, Yeung S. How antibiotics are used in pig farming: a mixed-methods study of pig farmers, feed mills and veterinarians in Thailand. BMJ Glob Health 2020;5:e001918. [PMID: 32180998 DOI: 10.1136/bmjgh-2019-001918] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
57 Sharma-Kuinkel BK, Zhang Y, Yan Q, Ahn SH, Fowler VG Jr. Host gene expression profiling and in vivo cytokine studies to characterize the role of linezolid and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) murine sepsis model. PLoS One 2013;8:e60463. [PMID: 23565251 DOI: 10.1371/journal.pone.0060463] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
58 Musolino C, Allegra A, Innao V, Allegra AG, Pioggia G, Gangemi S. Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma. Mediators Inflamm 2017;2017:1852517. [PMID: 29089667 DOI: 10.1155/2017/1852517] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 9.8] [Reference Citation Analysis]
59 Alhajlan M, Alhariri M, Omri A. Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors. Antimicrob Agents Chemother 2013;57:2694-704. [PMID: 23545534 DOI: 10.1128/AAC.00235-13] [Cited by in Crossref: 68] [Cited by in F6Publishing: 17] [Article Influence: 7.6] [Reference Citation Analysis]
60 Takemori N, Ooi HK, Imai G, Hoshino K, Saio M. Possible mechanisms of action of clarithromycin and its clinical application as a repurposing drug for treating multiple myeloma. Ecancermedicalscience 2020;14:1088. [PMID: 33014130 DOI: 10.3332/ecancer.2020.1088] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
61 Acosta N, Thornton CS, Surette MG, Somayaji R, Rossi L, Rabin HR, Parkins MD. Azithromycin and the microbiota of cystic fibrosis sputum. BMC Microbiol 2021;21:96. [PMID: 33784986 DOI: 10.1186/s12866-021-02159-5] [Reference Citation Analysis]
62 Andersson C, Bonvini SJ, Horvath P, Marquez E, Satia I, Kirkham P, Schleich F, Idzko M, Gosens R, Lopez-Campos JL, Bossios A, Usmani O, Spanevello A, Adcock IM, Mathioudakis AG. Research highlights from the 2017 ERS International Congress: airway diseases in focus. ERJ Open Res 2018;4:00163-2017. [PMID: 29546046 DOI: 10.1183/23120541.00163-2017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
63 Dey S, Bishayi B. Riboflavin along with antibiotics balances reactive oxygen species and inflammatory cytokines and controls Staphylococcus aureus infection by boosting murine macrophage function and regulates inflammation. J Inflamm (Lond) 2016;13:36. [PMID: 27932936 DOI: 10.1186/s12950-016-0145-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
64 Pérez-Del Palacio J, Díaz C, Vergara N, Algieri F, Rodríguez-Nogales A, de Pedro N, Rodríguez-Cabezas ME, Genilloud O, Gálvez J, Vicente F. Exploring the Role of CYP3A4 Mediated Drug Metabolism in the Pharmacological Modulation of Nitric Oxide Production. Front Pharmacol 2017;8:202. [PMID: 28446877 DOI: 10.3389/fphar.2017.00202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
65 Koumbourlis AC, Mastropietro C. Continuous Inhalation of Ipratropium Bromide for Acute Asthma Refractory to β2-agonist Treatment. J Pediatr Pharmacol Ther 2015;20:66-9. [PMID: 25859173 DOI: 10.5863/1551-6776-20.1.66] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Hirakawa H, Tomita H. Interference of bacterial cell-to-cell communication: a new concept of antimicrobial chemotherapy breaks antibiotic resistance. Front Microbiol 2013;4:114. [PMID: 23720655 DOI: 10.3389/fmicb.2013.00114] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
67 Saha A, Vaidya PJ, Chavhan VB, Achlerkar A, Leuppi JD, Chhajed PN. Combined pirfenidone, azithromycin and prednisolone in post-H1N1 ARDS pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2018;35:85-90. [PMID: 32476885 DOI: 10.36141/svdld.v35i1.6393] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
68 Baines KJ, Wright TK, Gibson PG, Powell H, Hansbro PM, Simpson JL. Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD. ERJ Open Res 2018;4:00031-2018. [PMID: 30406125 DOI: 10.1183/23120541.00031-2018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
69 Patterson Rosa L, Mallicote MF, MacKay RJ, Brooks SA. Ion Channel and Ubiquitin Differential Expression during Erythromycin-Induced Anhidrosis in Foals. Animals (Basel) 2021;11:3379. [PMID: 34944156 DOI: 10.3390/ani11123379] [Reference Citation Analysis]
70 Radzikowska E, Wiatr E, Langfort R, Bestry I, Skoczylas A, Szczepulska-Wójcik E, Gawryluk D, Rudziński P, Chorostowska-Wynimko J, Roszkowski-Śliż K. Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-Observational study. PLoS One 2017;12:e0184739. [PMID: 28945804 DOI: 10.1371/journal.pone.0184739] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
71 Kim SB, Ryoo S, Huh K, Joo EJ, Kim YJ, Choi WS, Kim YJ, Yoon YK, Heo JY, Seo YB, Jeong SJ, Park DA, Yu SY, Lee HJ, Kim J, Jin Y, Park J, Peck KR, Choi M, Yeom JS; Korean Society of Infectious Diseases (KSID). Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19. Infect Chemother 2021;53:166-219. [PMID: 34409790 DOI: 10.3947/ic.2021.0303] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
72 Rashad A, Nafady A, Hassan MH, Mansour H, Taya U, Bazeed SES, Aref ZF, Sayed MAA, Nafady-Hego H, Abdelmaksoud AA. Therapeutic efficacy of macrolides in management of patients with mild COVID-19. Sci Rep 2021;11:16361. [PMID: 34381155 DOI: 10.1038/s41598-021-95900-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
73 Fan LC, Lu HW, Wei P, Ji XB, Liang S, Xu JF. Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials. BMC Infect Dis 2015;15:160. [PMID: 25888483 DOI: 10.1186/s12879-015-0872-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
74 Dey S, Bishayi B. Killing of Staphylococcus aureus in murine macrophages by chloroquine used alone and in combination with ciprofloxacin or azithromycin. J Inflamm Res 2015;8:29-47. [PMID: 25653549 DOI: 10.2147/JIR.S76045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
75 Hao H, Gokulan K, Piñeiro SA, Williams KM, Yuan Z, Cerniglia CE, Khare S. Effects of Acute and Chronic Exposure to Residual Level Erythromycin on Human Intestinal Epithelium Cell Permeability and Cytotoxicity. Microorganisms 2019;7:E325. [PMID: 31489925 DOI: 10.3390/microorganisms7090325] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Konstantinidis T, Kambas K, Mitsios A, Panopoulou M, Tsironidou V, Dellaporta E, Kouklakis G, Arampatzioglou A, Angelidou I, Mitroulis I, Skendros P, Ritis K. Immunomodulatory Role of Clarithromycin in Acinetobacter baumannii Infection via Formation of Neutrophil Extracellular Traps. Antimicrob Agents Chemother 2016;60:1040-8. [PMID: 26643338 DOI: 10.1128/AAC.02063-15] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
77 Burns AL, Sleebs BE, Siddiqui G, De Paoli AE, Anderson D, Liffner B, Harvey R, Beeson JG, Creek DJ, Goodman CD, McFadden GI, Wilson DW. Retargeting azithromycin analogues to have dual-modality antimalarial activity. BMC Biol 2020;18:133. [PMID: 32993629 DOI: 10.1186/s12915-020-00859-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
78 Choudhary J, Dheeman S, Sharma V, Katiyar P, Karn SK, Sarangi MK, Chauhan AK, Verma G, Baliyan N. Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review. Biol Proced Online 2021;23:5. [PMID: 33526007 DOI: 10.1186/s12575-020-00141-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Park SJ, Kook JH, Kim HK, Kang SH, Lim SH, Kim HJ, Kim KW, Kim TH, Lee SH. Macrolides increase the expression of 11β-hydroxysteroid dehydrogenase 1 in human sinonasal epithelium, contributing to glucocorticoid activation in sinonasal mucosa. Br J Pharmacol 2015;172:5083-95. [PMID: 26228509 DOI: 10.1111/bph.13273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
80 Min JY, Jang YJ. Macrolide therapy in respiratory viral infections. Mediators Inflamm 2012;2012:649570. [PMID: 22719178 DOI: 10.1155/2012/649570] [Cited by in F6Publishing: 57] [Reference Citation Analysis]
81 Gualdoni GA, Lingscheid T, Schmetterer KG, Hennig A, Steinberger P, Zlabinger GJ. Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activation. Sci Rep 2015;5:12016. [PMID: 26152605 DOI: 10.1038/srep12016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
82 Tunney MM, Einarsson GG, Wei L, Drain M, Klem ER, Cardwell C, Ennis M, Boucher RC, Wolfgang MC, Elborn JS. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med 2013;187:1118-26. [PMID: 23348972 DOI: 10.1164/rccm.201210-1937OC] [Cited by in Crossref: 193] [Cited by in F6Publishing: 87] [Article Influence: 21.4] [Reference Citation Analysis]
83 Philpott C, le Conte S, Beard D, Cook J, Sones W, Morris S, Clarke CS, Thomas M, Little P, Vennik J, Lund V, Blackshaw H, Schilder A, Durham S, Denaxas S, Carpenter J, Boardman J, Hopkins C; MACRO programme team. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial. Trials 2019;20:246. [PMID: 31036048 DOI: 10.1186/s13063-019-3314-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
84 Panova N, Zborníková E, Šimák O, Pohl R, Kolář M, Bogdanová K, Večeřová R, Seydlová G, Fišer R, Hadravová R, Šanderová H, Vítovská D, Šiková M, Látal T, Lovecká P, Barvík I, Krásný L, Rejman D. Insights into the Mechanism of Action of Bactericidal Lipophosphonoxins. PLoS One 2015;10:e0145918. [PMID: 26716439 DOI: 10.1371/journal.pone.0145918] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
85 Feng F, Du J, Meng Y, Guo F, Feng C. Louqin Zhisou Decoction Inhibits Mucus Hypersecretion for Acute Exacerbation of Chronic Obstructive Pulmonary Disease Rats by Suppressing EGFR-PI3K-AKT Signaling Pathway and Restoring Th17/Treg Balance. Evid Based Complement Alternat Med 2019;2019:6471815. [PMID: 30800170 DOI: 10.1155/2019/6471815] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
86 Qiu S, Zhong X. Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease. Ther Adv Respir Dis 2017;11:147-55. [PMID: 28030992 DOI: 10.1177/1753465816682677] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
87 Ekmekciu I, von Klitzing E, Fiebiger U, Escher U, Neumann C, Bacher P, Scheffold A, Kühl AA, Bereswill S, Heimesaat MM. Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice. Front Immunol 2017;8:397. [PMID: 28469619 DOI: 10.3389/fimmu.2017.00397] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 10.6] [Reference Citation Analysis]
88 Van Nuffel AM, Sukhatme V, Pantziarka P, Meheus L, Sukhatme VP, Bouche G. Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent. Ecancermedicalscience 2015;9:513. [PMID: 25729426 DOI: 10.3332/ecancer.2015.513] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
89 Hörhold F, Eisel D, Oswald M, Kolte A, Röll D, Osen W, Eichmüller SB, König R. Reprogramming of macrophages employing gene regulatory and metabolic network models. PLoS Comput Biol 2020;16:e1007657. [PMID: 32097424 DOI: 10.1371/journal.pcbi.1007657] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
90 Soumya RS, Unni TG, Raghu KG. Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports. Cardiovasc Drugs Ther 2021;35:411-25. [PMID: 32926272 DOI: 10.1007/s10557-020-07073-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
91 Pollap A, Kochana J. Electrochemical Immunosensors for Antibiotic Detection. Biosensors (Basel) 2019;9:E61. [PMID: 31052356 DOI: 10.3390/bios9020061] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 10.7] [Reference Citation Analysis]
92 Parker EPK, Praharaj I, John J, Kaliappan SP, Kampmann B, Kang G, Grassly NC. Changes in the intestinal microbiota following the administration of azithromycin in a randomised placebo-controlled trial among infants in south India. Sci Rep 2017;7:9168. [PMID: 28835659 DOI: 10.1038/s41598-017-06862-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
93 Wang ZN, Su RN, Yang BY, Yang KX, Yang LF, Yan Y, Chen ZG. Potential Role of Cellular Senescence in Asthma. Front Cell Dev Biol 2020;8:59. [PMID: 32117985 DOI: 10.3389/fcell.2020.00059] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
94 Kazama I. Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease. J Physiol Sci 2015;65:25-35. [PMID: 25096892 DOI: 10.1007/s12576-014-0331-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
95 Zhou X, Zhang Y, Li Y, Hao X, Liu X, Wang Y. Azithromycin synergistically enhances anti-proliferative activity of vincristine in cervical and gastric cancer cells. Cancers (Basel) 2012;4:1318-32. [PMID: 24213508 DOI: 10.3390/cancers4041318] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
96 Bergström M, Müller M, Karlsson M, Scholz H, Vethe NT, Korsgren O. Comparing the Effects of the mTOR Inhibitors Azithromycin and Rapamycin on In Vitro Expanded Regulatory T Cells. Cell Transplant 2019;28:1603-13. [PMID: 31512504 DOI: 10.1177/0963689719872488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
97 Moges R, De Lamache DD, Sajedy S, Renaux BS, Hollenberg MD, Muench G, Abbott EM, Buret AG. Anti-Inflammatory Benefits of Antibiotics: Tylvalosin Induces Apoptosis of Porcine Neutrophils and Macrophages, Promotes Efferocytosis, and Inhibits Pro-Inflammatory CXCL-8, IL1α, and LTB4 Production, While Inducing the Release of Pro-Resolving Lipoxin A4 and Resolvin D1. Front Vet Sci 2018;5:57. [PMID: 29696149 DOI: 10.3389/fvets.2018.00057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
98 Teixeira-Santos R, Ricardo E, Branco RJ, Azevedo MM, Rodrigues AG, Pina-Vaz C. Unveiling the Synergistic Interaction Between Liposomal Amphotericin B and Colistin. Front Microbiol 2016;7:1439. [PMID: 27679618 DOI: 10.3389/fmicb.2016.01439] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
99 Vrančić M, Banjanac M, Nujić K, Bosnar M, Murati T, Munić V, Stupin Polančec D, Belamarić D, Parnham MJ, Eraković Haber V. Azithromycin distinctively modulates classical activation of human monocytes in vitro. Br J Pharmacol 2012;165:1348-60. [PMID: 21726210 DOI: 10.1111/j.1476-5381.2011.01576.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 6.0] [Reference Citation Analysis]
100 Cain DJ, Del Arroyo AG, Ackland GL. Uncontrolled sepsis: a systematic review of translational immunology studies in intensive care medicine. Intensive Care Med Exp 2014;2:6. [PMID: 26266907 DOI: 10.1186/2197-425X-2-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
101 Dhand R. The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis. J Aerosol Med Pulm Drug Deliv 2018;31:121-38. [PMID: 29077527 DOI: 10.1089/jamp.2017.1415] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
102 Hu H, Ramezanpour M, Hayes AJ, Liu S, Psaltis AJ, Wormald PJ, Vreugde S. Sub-Inhibitory Clindamycin and Azithromycin reduce S. aureus Exoprotein Induced Toxicity, Inflammation, Barrier Disruption and Invasion. J Clin Med 2019;8:E1617. [PMID: 31590226 DOI: 10.3390/jcm8101617] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
103 Pagliano P, Scarpati G, Sellitto C, Conti V, Spera AM, Ascione T, Piazza O, Filippelli A. Experimental Pharmacotherapy for COVID-19: The Latest Advances. J Exp Pharmacol 2021;13:1-13. [PMID: 33442304 DOI: 10.2147/JEP.S255209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
104 Mahashur A. Management of lower respiratory tract infection in outpatient settings: Focus on clarithromycin. Lung India 2018;35:143-9. [PMID: 29487250 DOI: 10.4103/lungindia.lungindia_262_17] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
105 Ramos I, Fernandez-Sesma A. Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs. Front Immunol 2015;6:361. [PMID: 26257731 DOI: 10.3389/fimmu.2015.00361] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 9.7] [Reference Citation Analysis]
106 Gouzos M, Ramezanpour M, Bassiouni A, Psaltis AJ, Wormald PJ, Vreugde S. Antibiotics Affect ROS Production and Fibroblast Migration in an In-vitro Model of Sinonasal Wound Healing. Front Cell Infect Microbiol 2020;10:110. [PMID: 32266162 DOI: 10.3389/fcimb.2020.00110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
107 Arason AJ, Joelsson JP, Valdimarsdottir B, Sigurdsson S, Gudjonsson A, Halldorsson S, Johannsson F, Rolfsson O, Lehmann F, Ingthorsson S, Cherek P, Gudmundsson GH, Gardarsson FR, Page CP, Baldursson O, Gudjonsson T, Kricker JA. Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia. Respir Res 2019;20:129. [PMID: 31234850 DOI: 10.1186/s12931-019-1101-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
108 Kawamura K, Ichikado K, Takaki M, Sakata Y, Yasuda Y, Shingu N, Tanaka A, Hisanaga J, Eguchi Y, Anan K, Nitawaki T, Suga M. Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysis. Springerplus 2016;5:1193. [PMID: 27516931 DOI: 10.1186/s40064-016-2866-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
109 Steel HC, Theron AJ, Cockeran R, Anderson R, Feldman C. Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics. Mediators Inflamm 2012;2012:584262. [PMID: 22778497 DOI: 10.1155/2012/584262] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 6.4] [Reference Citation Analysis]
110 Kamel AM, Monem MSA, Sharaf NA, Magdy N, Farid SF. Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials. Rev Med Virol 2021;:e2258. [PMID: 34077600 DOI: 10.1002/rmv.2258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
111 Kiser TH, Reynolds PM, Moss M, Burnham EL, Ho PM, Vandivier RW; Colorado Pulmonary Outcomes Research Group (CPOR). Impact of Macrolide Antibiotics on Hospital Readmissions and Other Clinically Important Outcomes in Critically Ill Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Propensity Score-Matched Cohort Study. Pharmacotherapy 2019;39:242-52. [PMID: 30663791 DOI: 10.1002/phar.2221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
112 Alves-Barroco C, Rivas-García L, Fernandes AR, Baptista PV. Tackling Multidrug Resistance in Streptococci - From Novel Biotherapeutic Strategies to Nanomedicines. Front Microbiol 2020;11:579916. [PMID: 33123110 DOI: 10.3389/fmicb.2020.579916] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
113 Wan KS, Liu YC, Huang CS, Su YM. Effects of low-dose clarithromycin added to fluticasone on inflammatory markers and pulmonary function among children with asthma: A randomized clinical trial. Allergy Rhinol (Providence) 2016;7:131-4. [PMID: 28107143 DOI: 10.2500/ar.2016.7.0168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
114 Imperi F, Leoni L, Visca P. Antivirulence activity of azithromycin in Pseudomonas aeruginosa. Front Microbiol 2014;5:178. [PMID: 24795709 DOI: 10.3389/fmicb.2014.00178] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 8.0] [Reference Citation Analysis]
115 Cazzola M, Rogliani P, Stolz D, Matera MG. Pharmacological treatment and current controversies in COPD. F1000Res 2019;8:F1000 Faculty Rev-1533. [PMID: 31508197 DOI: 10.12688/f1000research.19811.1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
116 Pani A, Lauriola M, Romandini A, Scaglione F. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology. Int J Antimicrob Agents. 2020;56:106053. [PMID: 32534189 DOI: 10.1016/j.ijantimicag.2020.106053] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 15.5] [Reference Citation Analysis]
117 McKimm-Breschkin JL, Jiang S, Hui DS, Beigel JH, Govorkova EA, Lee N. Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference. Antiviral Res 2018;149:118-42. [PMID: 29162476 DOI: 10.1016/j.antiviral.2017.11.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 9.0] [Reference Citation Analysis]
118 Adrie C, Schwebel C, Garrouste-Orgeas M, Vignoud L, Planquette B, Azoulay E, Kallel H, Darmon M, Souweine B, Dinh-Xuan AT, Jamali S, Zahar JR, Timsit JF; Article Was Written on behalf of the Outcomerea Study Group. Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance. Crit Care 2013;17:R265. [PMID: 24200097 DOI: 10.1186/cc13095] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
119 Hill K, Sucha E, Rhodes E, Carrier M, Garg AX, Harel Z, Hundemer GL, Clark EG, Knoll G, McArthur E, Sood MM. Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants. JAMA Intern Med 2020;180:1052-60. [PMID: 32511684 DOI: 10.1001/jamainternmed.2020.1835] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
120 Choo JM, Abell GCJ, Thomson R, Morgan L, Waterer G, Gordon DL, Taylor SL, Leong LEX, Wesselingh SL, Burr LD, Rogers GB. Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis. mSphere 2018;3:e00103-18. [PMID: 29669883 DOI: 10.1128/mSphere.00103-18] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
121 Fan LC, Xu JF. Advantages and drawbacks of long-term macrolide use in the treatment of non-cystic fibrosis bronchiectasis. J Thorac Dis 2014;6:867-71. [PMID: 25093082 DOI: 10.3978/j.issn.2072-1439.2014.07.24] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Dickson RP, Morris A. Macrolides, inflammation and the lung microbiome: untangling the web of causality. Thorax 2017;72:10-2. [PMID: 27799630 DOI: 10.1136/thoraxjnl-2016-209180] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
123 Usagawa Y, Komiya K, Yamasue M, Fushimi K, Hiramatsu K, Kadota JI. Efficacy of extracorporeal membrane oxygenation for acute respiratory failure with interstitial lung disease: a case control nationwide dataset study in Japan. Respir Res 2021;22:211. [PMID: 34303372 DOI: 10.1186/s12931-021-01805-w] [Reference Citation Analysis]
124 Han MK, Tayob N, Murray S, Dransfield MT, Washko G, Scanlon PD, Criner GJ, Casaburi R, Connett J, Lazarus SC, Albert R, Woodruff P, Martinez FJ. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. Am J Respir Crit Care Med 2014;189:1503-8. [PMID: 24779680 DOI: 10.1164/rccm.201402-0207OC] [Cited by in Crossref: 99] [Cited by in F6Publishing: 41] [Article Influence: 12.4] [Reference Citation Analysis]
125 Zin PPK, Williams G, Fourches D. SIME: synthetic insight-based macrolide enumerator to generate the V1B library of 1 billion macrolides. J Cheminform 2020;12:23. [PMID: 33431002 DOI: 10.1186/s13321-020-00427-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Sultana J, Cutroneo PM, Crisafulli S, Puglisi G, Caramori G, Trifirò G. Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines. Drug Saf 2020;43:691-8. [PMID: 32696429 DOI: 10.1007/s40264-020-00976-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
127 Batiha GE, Zayed MA, Awad AA, Shaheen HM, Mustapha S, Herrera-Calderon O, Pagnossa JP, Algammal AM, Zahoor M, Adhikari A, Pandey I, Elazab ST, Rengasamy KRR, Cruz-Martins N, Hetta HF. Management of SARS-CoV-2 Infection: Key Focus in Macrolides Efficacy for COVID-19. Front Med (Lausanne) 2021;8:642313. [PMID: 33937285 DOI: 10.3389/fmed.2021.642313] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Westblade LF, Simon MS, Satlin MJ. Bacterial coinfections in coronavirus disease 2019. Trends Microbiol 2021:S0966-842X(21)00094-9. [PMID: 33934980 DOI: 10.1016/j.tim.2021.03.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
129 Yang Y, Ashworth AJ, DeBruyn JM, Durso LM, Savin M, Cook K, Moore PA Jr, Owens PR. Antimicrobial resistant gene prevalence in soils due to animal manure deposition and long-term pasture management. PeerJ 2020;8:e10258. [PMID: 33194426 DOI: 10.7717/peerj.10258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
130 Takemori N, Kaneko H, Nakamura M, Kojima M. Complete Remission of Methotrexate-Related Epstein-Barr-Virus-Associated Hodgkin-Like Lymphoma following Withdrawal of MTX Coupled with Clarithromycin Administration. Case Rep Hematol 2012;2012:658745. [PMID: 23316401 DOI: 10.1155/2012/658745] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
131 Henkle E, Aksamit TR, Barker AF, Curtis JR, Daley CL, Anne Daniels ML, DiMango A, Eden E, Fennelly K, Griffith DE, Johnson M, Knowles MR, Leitman A, Leitman P, Malanga E, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Prieto D, Salathe M, Thomashow B, Tino G, Turino G, Wisclenny S, Winthrop KL. Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry. Chest 2017;152:1120-7. [PMID: 28479113 DOI: 10.1016/j.chest.2017.04.167] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
132 Borthwick LA, Wynn TA, Fisher AJ. Cytokine mediated tissue fibrosis. Biochim Biophys Acta 2013;1832:1049-60. [PMID: 23046809 DOI: 10.1016/j.bbadis.2012.09.014] [Cited by in Crossref: 194] [Cited by in F6Publishing: 188] [Article Influence: 19.4] [Reference Citation Analysis]
133 Ebrahimi A, Hosseini SA, Rahim F. Immunosuppressive therapy in allograft transplantation: from novel insights and strategies to tolerance and challenges. Cent Eur J Immunol 2014;39:400-9. [PMID: 26155155 DOI: 10.5114/ceji.2014.45955] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
134 Noureddin M, Zhang A, Loomba R. Promising therapies for treatment of nonalcoholic steatohepatitis. Expert Opin Emerg Drugs 2016;21:343-57. [PMID: 27501374 DOI: 10.1080/14728214.2016.1220533] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
135 Cain DJ, Del Arroyo AG, Ackland GL. Man is the new mouse: Elective surgery as a key translational model for multi-organ dysfunction and sepsis. J Intensive Care Soc 2015;16:154-63. [PMID: 28979398 DOI: 10.1177/1751143714564826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
136 Paff T, Omran H, Nielsen KG, Haarman EG. Current and Future Treatments in Primary Ciliary Dyskinesia. Int J Mol Sci 2021;22:9834. [PMID: 34575997 DOI: 10.3390/ijms22189834] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Segal LN, Rom WN, Weiden MD. Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs. Ann Am Thorac Soc 2014;11:108-16. [PMID: 24460444 DOI: 10.1513/AnnalsATS.201310-339FR] [Cited by in Crossref: 68] [Cited by in F6Publishing: 44] [Article Influence: 8.5] [Reference Citation Analysis]
138 Segal LN, Martinez FJ. Chronic obstructive pulmonary disease subpopulations and phenotyping. J Allergy Clin Immunol 2018;141:1961-71. [PMID: 29884286 DOI: 10.1016/j.jaci.2018.02.035] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
139 Suárez-Rivero JM, Pastor-Maldonado CJ, Povea-Cabello S, Álvarez-Córdoba M, Villalón-García I, Talaverón-Rey M, Suárez-Carrillo A, Munuera-Cabeza M, Sánchez-Alcázar JA. Mitochondria and Antibiotics: For Good or for Evil? Biomolecules 2021;11:1050. [PMID: 34356674 DOI: 10.3390/biom11071050] [Reference Citation Analysis]
140 Meseguer Barros CM, Alzueta Isturiz N, Sainz de Rozas Aparicio R, Vizcaíno RA, López Esteban L, Anaya Ordóñez S, Lekue Alkorta I, Martín Suances S, Jiménez Arce JI, Fernández Vicente M, Borrego Izquierdo Y, Prieto Sánchez R, Casado Casuso S, Madridejos R, Verde CM, Tomás Sanz R, Oro Fernández M, Gallardo Borge S, Lázaro López E, Pina Gadea MB, Pereira Pía M, Maestre-Sánchez MV, Ribes-Murillo E, Gómez de Oña C, María Jesús Lallana Á, Celaya Lecea C, Prado Prieto MA, Aranguez Ruiz A, Olmo Quintana V, Villén Romero N, Payá Giner C, Lloret Callejo A, Fernández Ferreiro A, Basagoiti Carreño B, Iglesias Iglesias AA, Martín Alonso A, Díez Alcántara A, Marco Tejón E, Lestón Vázquez M, Ariza Copado MÁ, Aparicio Cueva M, Escudero Vilaplana B, Nicieza M, Picazo Sanchiz G, Silva Riádigos GM, Sánchez LJ, García Álvarez Á, García Bonilla A, Herrero Delicado R, Arroyo Pineda V, de la Hija B, Troncoso Mariño A, Tofiño González I, Mateu García MS, García Vázquez P, Pérez Martín J, Fernández-Urrusuno R. Sars-Cov-2 Infection in Patients on Long-Term Treatment with Macrolides in Spain: A National Cross-Sectional Study. Antibiotics (Basel) 2021;10:1039. [PMID: 34572621 DOI: 10.3390/antibiotics10091039] [Reference Citation Analysis]
141 Huffman BJ, Shenvi RA. Natural Products in the "Marketplace": Interfacing Synthesis and Biology. J Am Chem Soc 2019;141:3332-46. [PMID: 30682249 DOI: 10.1021/jacs.8b11297] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
142 Kariya S, Okano M, Nishizaki K. Relationship between chronic rhinosinusitis and lower airway diseases: An extensive review. World J Otorhinolaryngol 2015; 5(2): 44-52 [DOI: 10.5319/wjo.v5.i2.44] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
143 Wilkening I, Gazzola S, Riva E, Parascandolo JS, Song L, Tosin M. Second-generation probes for biosynthetic intermediate capture: towards a comprehensive profiling of polyketide assembly. Chem Commun (Camb) 2016;52:10392-5. [PMID: 27481638 DOI: 10.1039/c6cc04681a] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
144 Wilson DW, Goodman CD, Sleebs BE, Weiss GE, de Jong NW, Angrisano F, Langer C, Baum J, Crabb BS, Gilson PR, McFadden GI, Beeson JG. Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum. BMC Biol 2015;13:52. [PMID: 26187647 DOI: 10.1186/s12915-015-0162-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
145 Morollón N, Belvís R, De Dios A, Pagès N, González-Oria C, Latorre G, Santos-Lasaosa S. Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group. Neurologia (Engl Ed) 2020;35:628-32. [PMID: 32896463 DOI: 10.1016/j.nrl.2020.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Heudobler D, Schulz C, Fischer JR, Staib P, Wehler T, Südhoff T, Schichtl T, Wilke J, Hahn J, Lüke F, Vogelhuber M, Klobuch S, Pukrop T, Herr W, Held S, Beckers K, Bouche G, Reichle A. A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung). Front Pharmacol 2021;12:599598. [PMID: 33796020 DOI: 10.3389/fphar.2021.599598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Naglah AM, Ahmed AF, Wen ZH, Al-Omar MA, Amr Ael-G, Kalmouch A. New Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Inhibitors, Nalidixic Acid Linked to Isatin Schiff Bases via Certain l-Amino Acid Bridges. Molecules 2016;21:498. [PMID: 27092477 DOI: 10.3390/molecules21040498] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
148 Sun XJ, He ZY. Macrolides for treatment of chronic obstructive pulmonary disease. Chin Med J (Engl) 2019;132:1261-3. [PMID: 30973449 DOI: 10.1097/CM9.0000000000000248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
149 Dos Santos WG. Natural history of COVID-19 and current knowledge on treatment therapeutic options. Biomed Pharmacother 2020;129:110493. [PMID: 32768971 DOI: 10.1016/j.biopha.2020.110493] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 18.0] [Reference Citation Analysis]
150 Castro-Filice LS, Barbosa BF, Angeloni MB, Silva NM, Gomes AO, Alves CM, Silva DA, Martins-Filho OA, Santos MC, Mineo JR, Ferro EA. Azithromycin is able to control Toxoplasma gondii infection in human villous explants. J Transl Med 2014;12:132. [PMID: 24885122 DOI: 10.1186/1479-5876-12-132] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
151 Lenz KD, Klosterman KE, Mukundan H, Kubicek-Sutherland JZ. Macrolides: From Toxins to Therapeutics. Toxins (Basel) 2021;13:347. [PMID: 34065929 DOI: 10.3390/toxins13050347] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
152 Meerwein M, Tarnutzer A, Böni M, Van Bambeke F, Hombach M, Zinkernagel AS. Increased Azithromycin Susceptibility of Multidrug-Resistant Gram-Negative Bacteria on RPMI-1640 Agar Assessed by Disk Diffusion Testing. Antibiotics (Basel) 2020;9:E218. [PMID: 32365460 DOI: 10.3390/antibiotics9050218] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
153 Gh MS, Wilhelm MJ, Dai HL. Azithromycin-Induced Changes to Bacterial Membrane Properties Monitored in Vitro by Second-Harmonic Light Scattering. ACS Med Chem Lett 2018;9:569-74. [PMID: 29937984 DOI: 10.1021/acsmedchemlett.7b00499] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
154 Chagan-Yasutan H, Chen Y, Lacuesta TL, Leano PS, Iwasaki H, Hanan F, Taurustiati D, Ohmoto Y, Ashino Y, Saitoh H, Kiyomoto H, Suzuki Y, Telan FO, Hattori T. Urine Levels of Defensin α1 Reflect Kidney Injury in Leptospirosis Patients. Int J Mol Sci 2016;17:E1637. [PMID: 27689992 DOI: 10.3390/ijms17101637] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
155 Inchingolo R, Pierandrei C, Montemurro G, Smargiassi A, Lohmeyer FM, Rizzi A. Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review. Antibiotics (Basel) 2021;10:326. [PMID: 33804631 DOI: 10.3390/antibiotics10030326] [Reference Citation Analysis]
156 Kazama I, Tamada T, Tachi M. Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases. Inflamm Res 2015;64:753-65. [PMID: 26206235 DOI: 10.1007/s00011-015-0855-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
157 Yen TT, Jiang RS, Chang CY, Wu CY, Liang KL. Erythromycin reduces nasal inflammation by inhibiting immunoglobulin production, attenuating mucus secretion, and modulating cytokine expression. Sci Rep 2021;11:21737. [PMID: 34741083 DOI: 10.1038/s41598-021-01192-8] [Reference Citation Analysis]
158 Corris PA, Ryan VA, Small T, Lordan J, Fisher AJ, Meachery G, Johnson G, Ward C. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. Thorax 2015;70:442-50. [PMID: 25714615 DOI: 10.1136/thoraxjnl-2014-205998] [Cited by in Crossref: 83] [Cited by in F6Publishing: 71] [Article Influence: 11.9] [Reference Citation Analysis]
159 Portlock CS, Hamlin PA, Gerecitano JF, Noy A, Palomba ML, Walkley J, Corcoran S, Migliacci J, Schoder H, Papanicolaou G, Markowitz AJ. A Positive Prospective Trial of Antibiotic Therapy in Advanced Stage, Non-Bulky Indolent Lymphoma. Tumor Microenviron Ther 2015;2:14-8. [PMID: 26798624 DOI: 10.1515/tumor-2015-0001] [Reference Citation Analysis]
160 RECOVERY Collaborative Group. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2021;397:605-12. [PMID: 33545096 DOI: 10.1016/S0140-6736(21)00149-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 46.0] [Reference Citation Analysis]
161 Lesan A, Lamle AE. Short review on the diagnosis and treatment of bronchiectasis. Med Pharm Rep 2019;92:111-6. [PMID: 31086836 DOI: 10.15386/cjmed-1060] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
162 Guarascio AJ, Ray SM, Finch CK, Self TH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res 2013;5:235-45. [PMID: 23818799 DOI: 10.2147/CEOR.S34321] [Cited by in Crossref: 47] [Cited by in F6Publishing: 148] [Article Influence: 5.2] [Reference Citation Analysis]
163 Mohammadi Barzelighi H, Daraei B, Dastan F. Approaches for the Treatment of SARS-CoV-2 Infection: A Pharmacologic View and Literature Review. Iran J Pharm Res 2020;19:258-81. [PMID: 33680028 DOI: 10.22037/ijpr.2020.113821.14506] [Reference Citation Analysis]
164 Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur J Clin Pharmacol 2012;68:479-503. [PMID: 22105373 DOI: 10.1007/s00228-011-1161-x] [Cited by in Crossref: 153] [Cited by in F6Publishing: 143] [Article Influence: 13.9] [Reference Citation Analysis]
165 Santana RR, Barbosa BO, Soares JRDO, Colombo RM, Santos VR, Amaral RG, Andrade LN. A critical analysis about the supposed role of azithromycin in the treatment of covid-19. Rev Cienc Saude 2021;11:11-21. [DOI: 10.21876/rcshci.v11i4.1184] [Reference Citation Analysis]
166 Hinks TSC, Barber VS, Black J, Dutton SJ, Jabeen M, Melhorn J, Rahman NM, Richards D, Lasserson D, Pavord ID, Bafadhel M. A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial. Trials 2020;21:718. [PMID: 32807209 DOI: 10.1186/s13063-020-04593-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
167 Lin CY, Yeh TL, Liu SJ, Lin HH, Cheng YJ, Hung HH, Tsai MC, Liu JM, Lei WT. Effects of Macrolide Treatment during the Hospitalization of Children with Childhood Wheezing Disease: A Systematic Review and Meta-Analysis. J Clin Med 2018;7:E432. [PMID: 30423980 DOI: 10.3390/jcm7110432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
168 Lajqi T, Pöschl J, Frommhold D, Hudalla H. The Role of Microbiota in Neutrophil Regulation and Adaptation in Newborns. Front Immunol 2020;11:568685. [PMID: 33133082 DOI: 10.3389/fimmu.2020.568685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
169 Vitiello A, Ferrara F. Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatment. Egypt Heart J 2021;73:103. [PMID: 34792677 DOI: 10.1186/s43044-021-00228-8] [Reference Citation Analysis]
170 Zafar M, Jahan H, Shafeeq S, Nimtz M, Jänsch L, Römling U, Choudhary MI. Clarithromycin Exerts an Antibiofilm Effect against Salmonella enterica Serovar Typhimurium rdar Biofilm Formation and Transforms the Physiology towards an Apparent Oxygen-Depleted Energy and Carbon Metabolism. Infect Immun 2020;88:e00510-20. [PMID: 32839186 DOI: 10.1128/IAI.00510-20] [Reference Citation Analysis]
171 Parrott GL, Kinjo T, Fujita J. A Compendium for Mycoplasma pneumoniae. Front Microbiol 2016;7:513. [PMID: 27148202 DOI: 10.3389/fmicb.2016.00513] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
172 Germovsek E, Barker CIS, Sharland M, Standing JF. Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance. Clin Pharmacokinet 2019;58:39-52. [PMID: 29675639 DOI: 10.1007/s40262-018-0659-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
173 Brown J, Simpson G. Diffuse panbronchiolitis in an Australian aborigine. Respirol Case Rep 2014;2:64-6. [PMID: 25473569 DOI: 10.1002/rcr2.50] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
174 Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifirò G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol 2020;11:588654. [PMID: 33240091 DOI: 10.3389/fphar.2020.588654] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
175 Idowu T, Schweizer F. Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities. Antibiotics (Basel) 2017;6:E26. [PMID: 29112154 DOI: 10.3390/antibiotics6040026] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 7.4] [Reference Citation Analysis]
176 Ullah M, Wahab A, Saeed S, Khan SU, Ali H, Humayun S, Abbasi BA, Saud S, Naveed K, Khan SA, Fahad S. Coronavirus and its terrifying inning around the globe: The pharmaceutical cares at the main frontline. Chemosphere 2021;275:129968. [PMID: 33652275 DOI: 10.1016/j.chemosphere.2021.129968] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
177 Kohanski MA, Tharakan A, Lane AP, Ramanathan M Jr. Bactericidal antibiotics promote reactive oxygen species formation and inflammation in human sinonasal epithelial cells. Int Forum Allergy Rhinol 2016;6:191-200. [PMID: 26624249 DOI: 10.1002/alr.21646] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
178 Park KH, Park HJ, Lee JH, Park JW. Single center experience of five diffuse panbronchiolitis patients clinically presenting as severe asthma. J Korean Med Sci 2015;30:823-8. [PMID: 26028938 DOI: 10.3346/jkms.2015.30.6.823] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
179 Gao YH, Guan WJ, Xu G, Tang Y, Gao Y, Lin ZY, Lin ZM, Zhong NS, Chen RC. Macrolide therapy in adults and children with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis. PLoS One 2014;9:e90047. [PMID: 24603554 DOI: 10.1371/journal.pone.0090047] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
180 Ma X, Jing Y, Liu Y, Yu L. Effect of clarithromycin in von Hippel-Lindau syndrome: a case report. J Int Med Res 2019;47:973-81. [PMID: 30178691 DOI: 10.1177/0300060518792368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
181 Fragkou PC, Belhadi D, Peiffer-Smadja N, Moschopoulos CD, Lescure FX, Janocha H, Karofylakis E, Yazdanpanah Y, Mentré F, Skevaki C, Laouénan C, Tsiodras S; ESCMID Study Group for Respiratory Viruses. Review of trials currently testing treatment and prevention of COVID-19. Clin Microbiol Infect 2020;26:988-98. [PMID: 32454187 DOI: 10.1016/j.cmi.2020.05.019] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 24.0] [Reference Citation Analysis]
182 Alves-Barroco C, Paquete-Ferreira J, Santos-Silva T, Fernandes AR. Singularities of Pyogenic Streptococcal Biofilms - From Formation to Health Implication. Front Microbiol 2020;11:584947. [PMID: 33424785 DOI: 10.3389/fmicb.2020.584947] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Damkjær M, Håkansson K, Kallemose T, Ulrik CS, Godtfredsen N. Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study. Int J Chron Obstruct Pulmon Dis 2021;16:579-89. [PMID: 33707941 DOI: 10.2147/COPD.S296472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
184 Angus DC, Berry S, Lewis RJ, Al-Beidh F, Arabi Y, van Bentum-Puijk W, Bhimani Z, Bonten M, Broglio K, Brunkhorst F, Cheng AC, Chiche JD, De Jong M, Detry M, Goossens H, Gordon A, Green C, Higgins AM, Hullegie SJ, Kruger P, Lamontagne F, Litton E, Marshall J, McGlothlin A, McGuinness S, Mouncey P, Murthy S, Nichol A, O'Neill GK, Parke R, Parker J, Rohde G, Rowan K, Turner A, Young P, Derde L, McArthur C, Webb SA. The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design. Ann Am Thorac Soc 2020;17:879-91. [PMID: 32267771 DOI: 10.1513/AnnalsATS.202003-192SD] [Cited by in Crossref: 75] [Cited by in F6Publishing: 45] [Article Influence: 37.5] [Reference Citation Analysis]
185 Makarova EV, Varvarina GN, Menkov NV, Czapaeva MY, Lazareva ES, Kazatskaya ZA, Novikov VV, Karaulov AV. [Nebulized budesonide in the treatment of exacerbations of chronic obstructive pulmonary disease: Efficacy, safety, and effects on the serum levels of soluble differentiation molecules]. Ter Arkh 2016;88:24-31. [PMID: 27030325 DOI: 10.17116/terarkh201688324-31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
186 Pawar AY. Combating devastating COVID-19 by drug repurposing. Int J Antimicrob Agents 2020;56:105984. [PMID: 32305589 DOI: 10.1016/j.ijantimicag.2020.105984] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 18.5] [Reference Citation Analysis]
187 Oda K, Yatera K, Fujino Y, Ishimoto H, Nakao H, Hanaka T, Ogoshi T, Kido T, Fushimi K, Matsuda S, Mukae H. Efficacy of concurrent treatments in idiopathic pulmonary fibrosis patients with a rapid progression of respiratory failure: an analysis of a national administrative database in Japan. BMC Pulm Med 2016;16:91. [PMID: 27278093 DOI: 10.1186/s12890-016-0253-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
188 Kwiatkowska B, Maślińska M. Macrolide therapy in chronic inflammatory diseases. Mediators Inflamm 2012;2012:636157. [PMID: 22969171 DOI: 10.1155/2012/636157] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
189 Komiya K, Ohta S, Arima K, Ogawa M, Suzuki S, Mitamura Y, Nunomura S, Nanri Y, Yoshihara T, Kawaguchi A, Kadota JI, Rubin BK, Izuhara K. Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts. Respir Res 2017;18:37. [PMID: 28219384 DOI: 10.1186/s12931-017-0519-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]